Your patient engagement infrastructure is heavily optimized for the 10% (activation)—enrollment, benefit verification, initial training. But you have limited visibility into the 90% of the patient journey where persistence is actually determined. 

Without visibility into the 90%, you likely experience:

• High discontinuation rates you can't explain
• Patient frustration with handoffs you don't see
• Inability to intervene before patients stop therapy
• Vendor metrics that look good while outcomes lag

Immediate Action: Map where your patient journey handoffs are breaking. Before you add another vendor or platform, understand where the 90% gaps exist.

Strategic Action: Rethink your infrastructure using the 90/10 Framework. You need ecosystem-level visibility, not just more point solutions

You have some visibility into the 90%, but your infrastructure is still primarily designed for activation moments. You likely have point solutions that work well individually but don't create a coherent patient experience across the ecosystem. 

You're better than most, but you're still:

• Reacting to problems instead of preventing them
• Managing vendors instead of patient journeys
• Unable to test and learn systematically
• Missing the early warning signs of discontinuation

Immediate Action: Identify which handoffs create the most friction. You don't need to fix everything—start with the one or two places where patients struggle most between your vendor touchpoints.

Strategic Action: Shift from vendor management to ecosystem design. You have good building blocks; they need to be connected around the patient experience, not vendor scopes

You're rare. You've built infrastructure that addresses the full patient journey—not just activation moments. You have ecosystem-level visibility, proactive intervention capability, and accountability for patient experience across vendors 

You understand the 90%. Now the question is execution:

• Are you measuring the ROI of your 90% infrastructure?
• Can you connect this infrastructure to business outcomes for CFOs and payers?
• Are you using this as competitive differentiation?

Immediate Action: Document what's working. You've solved the infrastructure problem most pharma companies struggle with—this is your competitive advantage.

Strategic Action: Build the business case. Your 90% infrastructure should translate to measurable improvements in persistence, real-world evidence, and cost-per-persistent-patient.